Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.03
Handel nachbörslich:
.03
0.03
+
Schlusskurs vom Vortag:
$0.03
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$1.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.96M
KGV:
0.00
EPS:
-0.7492
Netto-Cashflow:
$-19.63M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$0.831
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Compare ITRM vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.00 | 1.60M | 0 | -26.96M | -19.63M | -0.7492 |
VRTX
Vertex Pharmaceuticals Inc
|
547.29 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
814.79 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,047.10 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
149.66 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
215.44 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Iterum Therapeutics plc Revenue Breakdown – OTC:ITRMF - TradingView
Price to earnings forward of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Iterum Therapeutics (ITRM) Q2 2025 earnings summary - Quartr
Iterum Therapeutics plc Actuals & Estimates (OTC:ITRMF) - TradingView
ITRMF Forecast — Price Target — Prediction for 2027 - TradingView
Iterum Therapeutics PLC (ITRM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ITRMF Stock Price, News & Analysis - Stock Titan
ITRMF SEC FilingsIterum Therapeutics Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Iterum Therapeutics (ITRMF) files Form 25 to remove Ordinary Shares from Nasdaq - Stock Titan
Iterum Therapeutics (ITRM) Proxy Filing Summary - Quartr
Iterum Therapeutics PLC (ITRM) Institutional Confidence - TradingKey
Iterum Therapeutics PLC (ITRM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Iterum Therapeutics PLC (ITRM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Iterum Therapeutics PLC (ITRM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Iterum Therapeutics PLC (ITRM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Iterum Therapeutics PLC (ITRM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Iterum Therapeutics (ITRM) Holds at $0.03 as Micro-Cap Biotech Waits for CatalystsNew Listing Stocks - The Legal Advocate
Iterum Therapeutics (ITRM) Holds at $0.03 as Trading Volume Remains SubduedLow Risk Entry Stocks - dars.gov.et
Iterum (ITRM) Stalls at $$0.03 — Consolidation Phase 2026-05-15Social Sentiment - The Legal Advocate
Iterum Therapeutics PLC (ITRMF) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Iterum Therapeutics PLC (ITRMF) DCF Valuation - GuruFocus
Iterum Therapeutics PLC (ITRMF) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock Earnings Transcripts - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Competitors 2026 - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Dividend - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock Price & 30 Year Financial Data - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Valuation - GuruFocus
Iterum Therapeutics PLC Stock Operating Data - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
Who's Buying or Selling Iterum Therapeutics PLC (OTCM:ITRMF) Stock Today? - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) Stock News, Headlines & Updates - GuruFocus
Iterum Therapeutics PLC (OTCM:ITRMF) SEC filings - GuruFocus
ITERUM THERAPEUTICS PLC (ITRM) SHAREHOLDER CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Iterum Therapeutics plc - TMX Newsfile
Iterum Therapeutics PLC (ITRMF) - MSN
Iterum Therapeutics plc Financial Disclosures & SEC Filings - TradingView
Iterum Therapeutics (ITRM) Q3 2024 earnings summary - Quartr
Iterum Therapeutics (ITRM) Investor Presentation Summary - Quartr
Iterum Therapeutics (ITRM) FDA Announcement Summary - Quartr
Top pre-market gainers today — ELAB, ITRM, LTRN among stocks soaring before the bell - MSN
Iterum Therapeutics PLC (ITRMF) SEC filings - GuruFocus
ITRMF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Iterum Therapeutics plc (ITRMF) Competitors - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Down Today? - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Up Today? - Meyka
Iterum (ITRM) Stock Collar Strategy (Trend Strengthens) 2026-04-18Risk Analysis - Xã Thanh Hà
A 25-year pharma finance veteran takes over as Eton CFO on June 1 - Stock Titan
What's going on with Iterum Therapeutics stock Monday? - MSN
Retail Surge: Does Iterum Therapeutics plc outperform in volatile markets2026 Momentum & Comprehensive Market Scan Reports - baoquankhu1.vn
Dividend HistoryIterum Therapeutics (ITRMF) - Zacks Investment Research
Published on: 2026-04-10 21:42:25 - baoquankhu1.vn
Breakout Zone: What are the future prospects of Iterum Therapeutics plc2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):